Fenofibrate Activates PPARα-YAP Pathway for Liver Enlargemen
2026-06-05
This study demonstrates that Fenofibrate, a potent PPARα agonist, induces liver enlargement in both adult and aging mice by activating the PPARα-YAP signaling pathway. The findings clarify that age does not alter Fenofibrate’s effect on hepatic hypertrophy, offering new insights for aging and liver metabolism research.
Mycophenolic Acid as a Dehydrogenase Inhibitor: Experimental
2026-06-05
Harness the precision of mycophenolic acid in standardized immune metabolism assays and unlock robust cytokine modulation workflows. This article demystifies protocol optimization, troubleshooting, and cross-study advantages for immunometabolic research.
Allosteric PDK4 Inhibitors: New Paths for Metabolic Disease
2026-06-04
The referenced study introduces a novel series of allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, with compound 8c showing high potency, favorable pharmacokinetics, and efficacy in metabolic, allergic, and cancer models. These findings highlight allosteric PDK4 inhibition as a promising therapeutic strategy and provide a molecular scaffold for future drug development.
Apigenin: Translational Leverage from Oncology to Neuroprote
2026-06-04
This thought-leadership article unpacks the translational value of Apigenin (5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one) for researchers at the intersection of malignant mesothelioma and neurodegenerative disease. Integrating mechanistic insight, preclinical evidence, and strategic guidance, it positions APExBIO’s Apigenin as a scientifically validated, workflow-ready tool to advance both oncology and Alzheimer’s pipelines. The discussion bridges mechanistic HDAC inhibition, apoptosis regulation, and network medicine-derived neuroprotective effects, while critically assessing maturity and cross-domain limitations.
Next-Gen mRNA Reporters: Mechanistic Power and Translational
2026-06-03
Discover how advanced capped mRNAs like EZ Cap™ Firefly Luciferase mRNA bridge molecular biology and translational research, leveraging mechanistic insights and innovative delivery strategies—including antioxidant adjuvants—to redefine bioluminescent assays, translation efficiency, and in vivo imaging for the next era of mRNA therapeutics.
Self-Amplifying RNA Vaccines Show Superior Influenza Protect
2026-06-03
This study systematically compares self-amplifying RNA, nucleoside-modified mRNA, and circular RNA vaccine platforms for seasonal influenza. Self-amplifying RNA vaccines demonstrated enhanced immunogenicity, dose-sparing efficacy, and durable humoral responses across influenza subtypes, especially influenza B, compared to conventional mRNA approaches.
Patient-Derived Gastric Cancer Assembloids Advance Tumor-Str
2026-06-02
This study introduces a robust gastric cancer assembloid model that integrates patient-matched tumor organoids with autologous stromal subpopulations, enabling nuanced investigation of tumor–microenvironment interactions. The model more accurately predicts drug responses and resistance mechanisms, supporting the development of personalized cancer therapies.
Miltefosine in Leukopenia: Pathway-Specific Insights and Tra
2026-06-02
Explore how Miltefosine, a PI3K/Akt pathway inhibitor, delivers distinct hematopoietic benefits in leukopenia via dual pathway modulation. This article reveals unique, protocol-critical findings for translational research beyond existing Miltefosine content.
CX-5461: RNA Polymerase I Inhibitor Workflows in Cancer Rese
2026-06-01
CX-5461, a potent RNA polymerase I inhibitor, is redefining cancer research through its targeted disruption of ribosomal RNA synthesis and induction of non-apoptotic cell death pathways. This article delivers actionable, evidence-backed workflows and troubleshooting tips for leveraging CX-5461 in advanced solid tumor and chemoresistance models.
SU 5402: Advanced Inhibitor for Human Neuron and Cancer Mode
2026-06-01
Explore SU 5402 as a precision inhibitor in both cancer biology and advanced human iPSC-derived neuronal models. This article uniquely integrates molecular mechanisms, protocol guidance, and cross-domain insights for researchers.
Amphotericin B: Protocol Optimization for Fungal Infection R
2026-05-31
Amphotericin B remains the benchmark polyene antifungal antibiotic for dissecting fungal membrane dynamics and immune modulation in research models. This article translates recent synergy findings and bench-proven workflows into actionable protocols and troubleshooting strategies for advanced fungal infection studies.
Aprotinin in Cardiovascular Research: Workflow, Protocol, an
2026-05-30
Aprotinin (Bovine Pancreatic Trypsin Inhibitor, BPTI) is a precision tool for perioperative blood loss reduction and serine protease pathway interrogation in cardiovascular and molecular research. This article breaks down optimized workflows, protocol parameters, and troubleshooting strategies for advanced experimental applications, guided by recent innovations in RNA profiling and inflammation models.
Decoding Cell Death Pathways: Advanced Insights with the Hoe
2026-05-29
Explore how the Hoechst 33342/PI Double Staining Kit enables precise, fluorescence-based discrimination of apoptosis and necrosis, with advanced applications in cancer research. Gain unique insight into chromatin condensation and membrane integrity assays, and learn how recent discoveries inform optimal assay design.
DiR (DiIC 18 (7)) Redefines Long-Term Membrane Imaging & Ass
2026-05-29
Explore how DiR (DiIC 18 (7)) advances membrane imaging and cell tracking with exceptional sensitivity and duration. This in-depth article reveals the probe's unique advantages, protocols, and scientific insights for next-generation assay design.
Low-Affinity Blockade of N-Type Ca Channels by v-Agatoxin-IV
2026-05-28
Sidach and Mintz investigate the specificity and efficacy of the spider toxin v-agatoxin-IVA in blocking neuronal N-type calcium channels. Their findings challenge strict pharmacological definitions of P- and Q-type channels, revealing nuanced channel sensitivity to v-Aga-IVA and important implications for ion channel research and experimental design.
457 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page